San Francisco, CA (PRWEB) January 15, 2014
The Skikos firm reports that federal lawsuits against the manufacturer of NuvaRing continue to mount in recent weeks. On December 31, 2013, the latest group of cases was transferred to the Eastern District Court of Missouri, where all federal NuvaRing cases have been coordinated for pretrial proceedings. The latest transfer brings the total number of federal cases to 1,623.*
Plaintiffs allege that Merck and its subsidiary Organon failed to properly warn consumers about a heightened risk of blood clots associated with use of NuvaRing. The claimants allege the manufacturer was aware that NuvaRing posed greater risks than other hormonal contraceptives, but marketed the vaginal ring as equally safe and effective.
The coordinated federal action was initiated in August 2008 and is entitled In Re NuvaRing Products Liability Litigation, MDL No. 1964 (E.D. Mo.).**
As new cases continue to be transferred into to the federal court proceedings, the presiding judge ordered that litigation be put on hold. On January 9 2014, the court ordered that adversarial proceedings, including discovery, motions, and rulings related to any of the involved cases be held in abeyance for approximately five months.*** The Skikos firm could not comment on the reason for the court’s order, but lawyers with the firm note that the abeyance may give the parties an opportunity to negotiate the terms of a settlement agreement.
While the court suspended litigation, new claims may still be filed during the abeyance period and positioned for any upcoming NuvaRing settlement discussions. In the absence of a recall or other safety measures, lawyers expect the number of NuvaRing lawsuits to continue to rise before a settlement is reached.
Women who may have experienced blood clots while using NuvaRing are invited to contact the Skikos firm at (888) 870-1267 to discuss their legal options. The firm provides consultations nationwide at no cost and with no obligation to pursue a claim.